1. Home
  2. HALO vs CIEN Comparison

HALO vs CIEN Comparison

Compare HALO & CIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • CIEN
  • Stock Information
  • Founded
  • HALO 1998
  • CIEN 1992
  • Country
  • HALO United States
  • CIEN United States
  • Employees
  • HALO N/A
  • CIEN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • CIEN Telecommunications Equipment
  • Sector
  • HALO Health Care
  • CIEN Utilities
  • Exchange
  • HALO Nasdaq
  • CIEN Nasdaq
  • Market Cap
  • HALO 7.4B
  • CIEN 8.4B
  • IPO Year
  • HALO N/A
  • CIEN 1997
  • Fundamental
  • Price
  • HALO $52.02
  • CIEN $81.22
  • Analyst Decision
  • HALO Buy
  • CIEN Buy
  • Analyst Count
  • HALO 9
  • CIEN 13
  • Target Price
  • HALO $63.56
  • CIEN $78.62
  • AVG Volume (30 Days)
  • HALO 3.1M
  • CIEN 1.5M
  • Earning Date
  • HALO 05-06-2025
  • CIEN 06-05-2025
  • Dividend Yield
  • HALO N/A
  • CIEN N/A
  • EPS Growth
  • HALO 55.40
  • CIEN N/A
  • EPS
  • HALO 3.76
  • CIEN 0.55
  • Revenue
  • HALO $1,084,306,000.00
  • CIEN $4,049,506,000.00
  • Revenue This Year
  • HALO $24.79
  • CIEN $12.65
  • Revenue Next Year
  • HALO $22.65
  • CIEN $8.89
  • P/E Ratio
  • HALO $13.83
  • CIEN $147.80
  • Revenue Growth
  • HALO 25.64
  • CIEN N/A
  • 52 Week Low
  • HALO $41.28
  • CIEN $44.69
  • 52 Week High
  • HALO $70.51
  • CIEN $101.44
  • Technical
  • Relative Strength Index (RSI)
  • HALO 39.78
  • CIEN 74.40
  • Support Level
  • HALO $47.50
  • CIEN $78.46
  • Resistance Level
  • HALO $69.94
  • CIEN $81.48
  • Average True Range (ATR)
  • HALO 3.52
  • CIEN 2.30
  • MACD
  • HALO -1.49
  • CIEN 1.15
  • Stochastic Oscillator
  • HALO 19.64
  • CIEN 98.45

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CIEN Ciena Corporation

Ciena Corp is a network and technology company. It provides network hardware, software, and services that support the transport, switching, aggregation, service delivery, and management of video, data, and voice traffic on communications networks. It serves various industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises world-wide. The business activities function through Networking Platforms which generates maximum revenue; Platform Software and Services; Blue Planet Automation Software, and Global Services segments. Geographically, the company derives a majority of its revenue from the Americas, and the rest from the Asia-Pacific (APAC), and Europe, Middle East, and Africa (EMEA) region.

Share on Social Networks: